Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Becton Dickinson's share price for the quarter that ended in Mar. 2025 was $229.06. Becton Dickinson's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 287 Mil. Therefore, Becton Dickinson's market cap for the quarter that ended in Mar. 2025 was $65,650 Mil.
Becton Dickinson's quarterly market cap
declined
from Sep. 2024 ($69,702 Mil) to Dec. 2024 ($65,142 Mil) but then
increased
from Dec. 2024 ($65,142 Mil) to Mar. 2025 ($65,650 Mil).
Becton Dickinson's annual market cap
increased
from Sep. 2022 ($63,140 Mil) to Sep. 2023 ($75,075 Mil) but then
declined
from Sep. 2023 ($75,075 Mil) to Sep. 2024 ($69,702 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Becton Dickinson's Enterprise Value for Today is $66,961 Mil.
Becton Dickinson Market Cap Historical Data
The historical data trend for Becton Dickinson's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Becton Dickinson's Market Cap
For the Medical Instruments & Supplies subindustry, Becton Dickinson's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Becton Dickinson's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Market Cap distribution charts can be found below:
* The bar in red indicates where Becton Dickinson's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Becton Dickinson's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Becton Dickinson (NYSE:BDX) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Becton Dickinson Market Cap Related Terms
Thank you for viewing the detailed overview of Becton Dickinson's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BDX has been successfully added to your 